SurgePays (NASDAQ:SURG – Get Free Report) will be releasing its earnings data after the market closes on Tuesday, November 12th. Analysts expect SurgePays to post earnings of ($0.22) per share for the quarter.
SurgePays (NASDAQ:SURG – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The medical equipment provider reported ($0.66) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.49). The business had revenue of $15.09 million for the quarter, compared to analyst estimates of $9.02 million. SurgePays had a negative return on equity of 3.97% and a negative net margin of 1.36%. On average, analysts expect SurgePays to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
SurgePays Price Performance
Shares of NASDAQ SURG opened at $1.64 on Wednesday. The business’s 50 day moving average price is $1.68 and its two-hundred day moving average price is $2.69. The company has a market cap of $32.39 million, a PE ratio of 18.22 and a beta of 0.94. The company has a quick ratio of 6.11, a current ratio of 7.38 and a debt-to-equity ratio of 0.07. SurgePays has a twelve month low of $1.33 and a twelve month high of $9.23.
Insider Activity
In other news, CFO Anthony George Evers sold 33,334 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $1.54, for a total value of $51,334.36. Following the transaction, the chief financial officer now owns 261,590 shares of the company’s stock, valued at approximately $402,848.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO Kevin Brian Cox sold 35,100 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $1.48, for a total transaction of $51,948.00. Following the sale, the chief executive officer now owns 5,786,012 shares of the company’s stock, valued at $8,563,297.76. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Anthony George Evers sold 33,334 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $1.54, for a total value of $51,334.36. Following the sale, the chief financial officer now owns 261,590 shares of the company’s stock, valued at $402,848.60. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 91,434 shares of company stock valued at $103,514. 29.40% of the stock is owned by insiders.
Analysts Set New Price Targets
Separately, Ascendiant Capital Markets decreased their target price on SurgePays from $9.50 to $9.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th.
Check Out Our Latest Report on SURG
SurgePays Company Profile
SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.
Recommended Stories
- Five stocks we like better than SurgePays
- Following Congress Stock Trades
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- Most Volatile Stocks, What Investors Need to Know
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Receive News & Ratings for SurgePays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurgePays and related companies with MarketBeat.com's FREE daily email newsletter.